Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank van Hees

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
JAMA Internal Medicine|August 19, 2014
The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling studyFrank van Hees, Ann G Zauber, Carrie N Klabunde, et al.
Annals of Internal Medicine|June 3, 2014
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysisFrank van Hees, J Dik F Habbema, Reinier G Meester, et al.
Oncology and Therapy|November 5, 2024
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United StatesBradley J Monk, Sophie van Mens, Oliver Hale, et al.
Gut|June 12, 2015
The value of models in informing resource allocation in colorectal cancer screening: the case of The NetherlandsFrank van Hees, Ann G Zauber, Harriët van Veldhuizen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 10, 2016
Calibrating Parameters for Microsimulation Disease Models: A Review and Comparison of Different Goodness-of-Fit CriteriaAlex van der Steen, Joost van Rosmalen, Sonja Kroep, et al.
Gastroenterology|August 9, 2015
Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectivenessFrank van Hees, Sameer D Saini, Iris Lansdorp-Vogelaar, et al.
Journal of Medical Economics|February 21, 2022
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United StatesRaquel Aguiar-Ibáñez, Chloë Hardern, Frank van Hees, et al.
Endoscopy|May 12, 2016
Developing a score chart to improve risk stratification of patients with colorectal adenomaElse-Mariëtte B van Heijningen, Iris Lansdorp-Vogelaar, Frank van Hees, et al.
International Journal of Cancer|February 10, 2015
The impact of stratifying by family history in colorectal cancer screening programsSimon Lucas Goede, Linda Rabeneck, Iris Lansdorp-Vogelaar, et al.
Health Services Research|October 18, 2014
Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South CarolinaAlex van der Steen, Amy B Knudsen, Frank van Hees, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
JAMA Internal Medicine|August 19, 2014
The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling studyFrank van Hees, Ann G Zauber, Carrie N Klabunde, et al.
Annals of Internal Medicine|June 3, 2014
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysisFrank van Hees, J Dik F Habbema, Reinier G Meester, et al.
Oncology and Therapy|November 5, 2024
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United StatesBradley J Monk, Sophie van Mens, Oliver Hale, et al.
Gut|June 12, 2015
The value of models in informing resource allocation in colorectal cancer screening: the case of The NetherlandsFrank van Hees, Ann G Zauber, Harriët van Veldhuizen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 10, 2016
Calibrating Parameters for Microsimulation Disease Models: A Review and Comparison of Different Goodness-of-Fit CriteriaAlex van der Steen, Joost van Rosmalen, Sonja Kroep, et al.
Gastroenterology|August 9, 2015
Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectivenessFrank van Hees, Sameer D Saini, Iris Lansdorp-Vogelaar, et al.
Journal of Medical Economics|February 21, 2022
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United StatesRaquel Aguiar-Ibáñez, Chloë Hardern, Frank van Hees, et al.
Endoscopy|May 12, 2016
Developing a score chart to improve risk stratification of patients with colorectal adenomaElse-Mariëtte B van Heijningen, Iris Lansdorp-Vogelaar, Frank van Hees, et al.
International Journal of Cancer|February 10, 2015
The impact of stratifying by family history in colorectal cancer screening programsSimon Lucas Goede, Linda Rabeneck, Iris Lansdorp-Vogelaar, et al.
Health Services Research|October 18, 2014
Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South CarolinaAlex van der Steen, Amy B Knudsen, Frank van Hees, et al.
Pageof 2